How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline Updated March 14, 2022 | Biosimilars Law Bulletin
Pfenex: The First U.S. Forteo Biosim And A Host Of Other Biosims In Pipeline (NYSEMKT:PFNX) | Seeking Alpha
How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline Updated March 14, 2022 | Biosimilars Law Bulletin
Lilly faces biosimilar rivals to osteoporosis drug Forsteo in Europe | pharmaphorum
Teva Raises Guidance Amid Generics Growth :: Generics Bulletin
Biosimilars Law Bulletin | Rothwell Figg | Biologics and Biosimilars Practice
Teva Pharma is the way to play the re-rise of generic drugs
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S. -November 17, 2023 at 08:31 am EST | MarketScreener
EX-99.1
Teva Pharmaceutical Industries Ltd. - Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S. | Business Wire
Teriparatide - Wikipedia
Teva announces approval of a generic version of Forteo in US
Stada Arz in-licenses teriparatide, expanding its biosimilars portfoli
Strides Says Forsteo Biosimilar 'Significant Product', Seeks New Minority Investor In Stelis :: Scrip
Teva's Research Pipeline to Culminate in Many New Drug Launches?
Pfenex: The First U.S. Forteo Biosim And A Host Of Other Biosims In Pipeline (NYSEMKT:PFNX) | Seeking Alpha
EX-99.1
Teva Pharmaceutical Industries Ltd.
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.
Teva announces approval of a generic version of Forteo in US
FDA approves generic teriparatide and levetiracetam
Pfenex's New CEO Sizes Up Biosimilar Industry's Future
How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline | Biosimilars Law Bulletin
biosimilars
Osteoporosis Injection Treatment | FORTEO® (teriparatide injection)
Hitting A Moving Target: Teva's Dethlefs Discusses US Complex Generics :: Generics Bulletin
